EIC Accelerator

EIC Accelerator Challenge: Biotech for Regenerating Agricultural Soils

Supports scaling deep-tech for soil health, sustainability, and resilience of EU agriculture.

Eligibility · EU member states + Horizon-associated

The EIC Accelerator Challenge on Biotech for Regenerating Agricultural Soils targets deep-tech SMEs developing solutions that improve soil health and enhance the sustainability, efficiency, and resilience of the European agricultural sector across food, feed, and biomass applications. With a €44 million budget for 2026, the challenge addresses growing concern about degraded agricultural land across EU Member States and the need for science-based interventions that can be commercially scaled. Eligible technologies span the full range of relevant approaches — microbial inoculants, precision fermentation inputs, biosensors, synthetic biology tools for soil microbiome engineering, and biotech-derived soil amendments — provided they are being brought to market by a single SME rather than a research consortium.

Award structure follows the standard EIC Accelerator model: a non-dilutive grant of up to €2.5 million for prototype and demonstrator work at TRL 5–8, combined with EIC Fund equity of €1–10 million for the subsequent commercialisation phase. The application process runs through the same four steps and six bimonthly Step-2 cut-offs (January, March, May, July, September, November 2026) as the broader Accelerator programme. Eligibility is restricted to single SMEs registered in an EU Member State or Horizon Europe Associated Country, with up to 250 employees. UK applicants may apply for the grant component only. Proposals meeting quality thresholds but not awarded funding receive the STEP Sovereignty Seal.

For applicants, this challenge intersects agritech, biotechnology, and environmental remediation — a combination that favours proposals demonstrating both agronomic efficacy and a commercial pathway into mainstream farming practice. Evaluators will weigh environmental impact credentials (carbon sequestration, reduced synthetic inputs) alongside scalability and farmer adoption dynamics. Companies working at the intersection of synthetic biology and agricultural application are well positioned, as are those with field-validated data from relevant European soil types and regulatory dossiers already in progress for key markets.